Evaluation of pseudoprogression in patients with glioblastoma multiforme using dynamic magnetic resonance imaging with ferumoxytol calls RANO criteria into question

BACKGROUND: Diagnosis of pseudoprogression in patients with glioblastoma multiforme (GBM) is limited by Response Assessment in Neuro-Oncology (RANO) criteria to 3 months after chemoradiotherapy (CRT). Frequency of pseudoprogression occurring beyond this time limit was determined. Survival comparison...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Nasseri, Morad, Gahramanov, Seymur, Netto, Joao Prola, Fu, Rongwei, Muldoon, Leslie L., Varallyay, Csanad, Hamilton, Bronwyn E., Neuwelt, Edward A.
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2014
Assuntos:
Neuroimaging
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4096172/
https://ncbi.nlm.nih.gov/pubmed/24523362
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/not328
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados